| Date Filed | Type | Description |
| 10/03/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 9,167 shares
@ $1.5, valued at
$13.8k
|
|
| 10/03/2023 |
4
| Andrews Patricia S (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 8,167 shares
@ $1.5, valued at
$12.3k
|
|
| 10/03/2023 |
4
| King Rachel K. (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 6,667 shares
@ $1.5, valued at
$10k
|
|
| 08/02/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/18/2023 |
4
| Hahn Brian M. (SVP Finance, CFO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 3,700 shares
@ $1.95, valued at
$7.2k
|
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4
| JUNIUS DANIEL M (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 30,000 shares
@ $1.56, valued at
$46.8k
|
|
| 05/09/2023 |
4
| Johnson Bruce S (SVP & Chief Commercial Officer) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 13,500 shares
@ $1.57, valued at
$21.2k
|
|
| 05/03/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2023 |
3
| Rath Chinmaya (SVP and Chief Business Officer) has filed a Form 3 on GLYCOMIMETICS INC |
| 03/31/2023 |
3
| Johnson Bruce S (SVP & Chief Commercial Officer) has filed a Form 3 on GLYCOMIMETICS INC |
| 03/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/02/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/28/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 100,000 shares
@ $1.7, valued at
$170k
|
|
| 02/23/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 50,000 shares
@ $1.85, valued at
$92.5k
Bought 150,000 shares
@ $1.7933, valued at
$269k
Bought 200,000 shares
@ $1.7538, valued at
$350.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/06/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Exercised 10,500 options to buy
@ $2.55, valued at
$26.8k
|
|
| 01/27/2023 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 358,371 shares
@ $3.2639, valued at
$1.2M
Sold 293,645 shares
@ $3.2639, valued at
$958.4k
Sold 1,648,908 shares
@ $3.1188, valued at
$5.1M
Sold 1,351,092 shares
@ $3.1188, valued at
$4.2M
|
|
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|